Association of AKT expression with degree of pathologic response in patients with esophageal cancer undergoing neoadjuvant therapy.

被引：1
|
作者：
Saeed, Nadia
Doepker, Matthew
Shridhar, Ravi
Weber, Jill
Hoffe, Sarah E.
Almhanna, Khaldoun
Meredith, Kenneth L.
机构：
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Radiat Oncol, Tampa, FL 33682 USA
[3] Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
10.1200/jco.2015.33.3_suppl.89
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
89
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Complete pathologic response to neoadjuvant chemoradiation is the only predictor of survival in patients with esophageal cancer
    Meredith, K. L.
    Weber, J.
    Siegel, E.
    McLoughlin, J.
    Taruga, K.
    Shah, N.
    Melis, M.
    Kelley, S.
    Karl, R.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 26 - 26
  • [32] Pre-Neoadjuvant Therapy Clinical Staging Predicts Overall Survival in Esophageal Cancer Patients with Pathologic Complete Response
    Gangi, A.
    Hoffe, S.
    Frakes, J.
    Almhanna, K.
    Pena, L.
    Fontaine, J.
    Blackham, A.
    Pimiento, J. M.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S151 - S151
  • [33] The Important Prognostic Value of Pretreatment Stage in Patients Achieving Pathologic Complete Response After Neoadjuvant Therapy of Esophageal Cancer
    Yang, J.
    Xiao, Z.
    Tan, L.
    Zhou, Z.
    Feng, Q.
    Wang, L.
    Zhang, H.
    Chen, D.
    Liang, J.
    Hui, Z.
    Yin, W.
    He, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S351 - S351
  • [34] The Important Prognostic Value of Pretreatment Stage in Patients Achieving Pathologic Complete Response After Neoadjuvant Therapy of Esophageal Cancer
    Yang, J.
    Xiao, Z.
    Tan, L.
    Zhou, Z.
    Feng, Q.
    Wang, L.
    Zhang, H.
    Chen, D.
    Liang, J.
    Hui, Z.
    Yin, W.
    He, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S26 - S27
  • [35] Predicting response to neoadjuvant therapy in esophageal cancer
    Vallboehmer, Daniel
    Brabender, Jan
    Grimminger, Peter
    Schroeder, Wolfgang
    Hoelscher, Arnulf H.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (09) : 1449 - 1455
  • [36] Doxorubicin response prediction in neoadjuvant breast cancer therapy.
    Buhl, Anna Sofie Kappel
    Christensen, Ib Jarle
    Knudsen, Steen
    Jensen, Peter Buhl
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] Metallothionein expression correlates with the pathological response of patients with esophageal cancer undergoing preoperative chemoradiation therapy
    Yamamoto, M
    Tsujinaka, T
    Shiozaki, H
    Doki, Y
    Tamura, S
    Inoue, M
    Hirao, M
    Monden, M
    ONCOLOGY, 1999, 56 (04) : 332 - 337
  • [38] RECTAL CANCER BIOMARKERS AS PREDICTORS OF RESPONSE TO NEOADJUVANT THERAPY.
    Douglas, J. K.
    Hothem, Z. A.
    Wasvary, H.
    Cousineau, C.
    Peeples, C.
    Thibodeau, B.
    Li, W.
    Kawak, S.
    DISEASES OF THE COLON & RECTUM, 2018, 61 (05) : E156 - E156
  • [39] A validated miRNA expression profile for response to neoadjuvant therapy in esophageal cancer.
    Skinner, Heath D.
    Xu, Enping
    Lee, Jeffrey H.
    Bhutani, Manoop S.
    Weston, Brian
    Suzuki, Akihiro
    Hofstetter, Wayne Lewis
    Komaki, Ritsuko
    Ajani, Jaffer A.
    Wu, Xifeng
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [40] Preoperative placement of polyflex esophageal stents in patients with locally advanced esophageal cancer undergoing neoadjuvant therapy
    Wills, Jason
    Wong, Robert
    Hilden, Kristen
    Fang, John
    Adler, Douglas
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S9 - S9
12345